Skip to content

The clinical efficacy study of selecting embryos by non-invasive embryo chromosome screening (NICS) technology

Clinical Application of on-invasive embryo chromosome screening (NICS) technology

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200058647
Enrollment
Unknown
Registered
2022-04-13
Start date
2022-04-30
Completion date
Unknown
Last updated
2024-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Interventions

NICS group:NICS TEST

Sponsors

Women's Hospital School Of Medicine Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 42 Years

Inclusion criteria

Inclusion criteria: 1. Women's age: 20-42; 2. IVF/ICSI fertilization patients; 3. Whole embryo freezing during egg taking cycle; 4. After 4 embryos at cleavage stage are frozen, the number of frozen blastocysts can be = 2.

Exclusion criteria

Exclusion criteria: 1. PGT cycle assisted pregnancy; 2. Uterine diseases that may affect implantation (including the history of uterine cavity adhesion, submucous myoma,>4cm muscle wall, endometrial myoma, adenomyosis); 3. There is hydrosalpinx and no proximal tubal ligation; 4. Serious endocrine disease; 5. Severe heart disease, unstable angina, cardiac insufficiency above grade III, acute myocardial infarction and/or old myocardial infarction; 6. People with bad habits of alcohol, drug and drug abuse; 7. HIV or syphilis positive; 8. The researcher thinks that it is not suitable for this study.

Design outcomes

Primary

MeasureTime frame
Ongoing pregnancy rate;

Secondary

MeasureTime frame
Clinical pregnancy rate;Miscarriage rate;Live birth rate;

Countries

China

Contacts

Public ContactYinghui Ye

Women's Hospital School Of Medicine Zhejiang University

yeyh1999@zju.edu.cn+86 13805730795

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026